Skip to content

Feasibility study of an orthosis for treatment of Knee Osteoarthritis

Feasibility study of an orthosis for treatment of Knee Osteoarthritis - Orthosis in knee osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON47115
Enrollment
10
Registered
2017-06-27
Start date
2017-11-26
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

degenerative joint disease Osteoarthritis of the knee

Interventions

during two months patients use an non-weight bearing orthosis

Sponsors

Martini Ziekenhuis
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: • age between 25 and 60 years • primary unilateral osteoarthritis in the tibiofemoral joint • severity of osteoarthritis: moderate to severe (KL2 or higher) but below the level required for joint replacement

Exclusion criteria

Exclusion criteria: • symptomatic osteoarthritis in both knees • generalized osteoarthritis (genetic) • mechanical axis deviations > 10° • psychological problems that would hinder wearing the orthosis • primary retro patellar osteoarthritis • BMI >= 30 • Balance problems (ASA 3 or higher)

Design outcomes

Primary

MeasureTime frame
The primary outcome is the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) (Bellamy et al. 1988), an osteoarthritis specific questionnaire for pain, stiffness and functioning between pre-intervention and after 24 months.

Secondary

MeasureTime frame
- the Western Ontario and McMaster Universities Osteoarthritis (WOMAC) (Bellamy et al. 1988) between all other time-points. - Visual Analogue Scale (VAS) scores for pain (Bijur et al, 2001; Downie et al, 1978) between all time-points. - assessment of articular cartilage volume with MRI (using the GENERIC protocol) between all time-points. - severity of osteoarthritis determined with standardized knee X-rays between all time-points - Visual Analogue Scale (VAS) score for satisfaction about the treatment result at two year follow-up

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)